Fast-tracking regenerative medicine for traumatic brain injury
Fast-tracking regenerative medicine for traumatic brain injury作者机构:Center of Excellence for Aging and Brain Repair University of South Florida College of Medicine
出 版 物:《Neural Regeneration Research》 (中国神经再生研究(英文版))
年 卷 期:2020年第15卷第7期
页 面:1179-1190页
核心收录:
学科分类:1002[医学-临床医学] 100210[医学-外科学(含:普外、骨外、泌尿外、胸心外、神外、整形、烧伤、野战外)] 10[医学]
基 金:CVB was funded by National Institutes of Health(NIH)R01NS071956,NIH R01NS090962,NIH R21NS089851,NIH R21NS094087 Veterans Affairs Merit Review I01 BX001407
主 题:clinical trials combined therapy inflammatory cascade neuroinflammation neuroprotection neurotrauma pharmacotherapy preclinical studies secondary cell death stem cells
摘 要:Traumatic brain injury remains a global health crisis that spans all demographics,yet there exist limited treatment options that may effectively curtail its lingering *** brain injury pathology entails a progression from primary injury to inflammation-mediated secondary cell *** this inflammation as a means of ameliorating the greater symptomology of traumatic brain injury has emerged as an attractive treatment *** this review,we recapitulate and evaluate the important developments relating to regulating traumatic brain injury-induced neuroinflammation,edema,and blood-brain barrier disintegration through pharmacotherapy and stem cell *** these studies of stand-alone treatments have yielded some positive results,more therapeutic outcomes have been documented from the promising area of combined drug and stem cell *** the facilitatory properties of certain pharmaceuticals with the anti-inflammatory and regenerative effects of stem cell transplants creates a synergistic effect greater than the sum of its *** burgeoning evidence in favor of combined drug and stem cell therapies warrants more elaborate preclinical studies on this topic in order to pave the way for later clinical trials.